Treatment of Geographic Atrophy: What’s on the Horizon?

Mariana R. Thorell, Philip J. Rosenfeld

Research output: Contribution to journalArticlepeer-review


Currently, there is no treatment to stop the progression of geographic atrophy, the advanced form of non-exudative (dry) age-related macular degeneration. Several promising therapies are being investigated in clinical trials such as antioxidants, neuroprotection agents, complement inhibitors, vascular enhancers, visual cycle modulators, and stem cell therapies. This review discusses the possible treatments that may potentially be available in the future to prevent disease progression.

Original languageEnglish (US)
Pages (from-to)20-25
Number of pages6
JournalCurrent Ophthalmology Reports
Issue number1
StatePublished - Mar 1 2014


  • Age-related macular degeneration (AMD)
  • Cell therapies
  • Dry AMD
  • Ophthalmology
  • Treatment of geographic atrophy

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Treatment of Geographic Atrophy: What’s on the Horizon?'. Together they form a unique fingerprint.

Cite this